What is ADMA Biologics's number of FDA approved product?

ADMA Biologics (ADMA) reported number of FDA approved product of 3 in Q1 2026.

What does number of FDA approved product mean?

The total count of proprietary products that have received formal regulatory authorization for commercial sale. This metric measures the maturity of the product pipeline and the company's ability to successfully navigate the clinical and regulatory approval process.

ADMA Biologics ADMA Number Of FDA Approved Product

Number Of FDA Approved Product at other companies

NuScale PowerSMR

30.0%

ModernaMRNA

3+50.0%

ExelixisEXEL

20.0%

ZoetisZTS

10,000%0.0pp

ExelixisEXEL

40.0%

ANI PharmaceuticalsANIP

$6.3M+14.5%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.02B-54.5%

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept adma:NumberOfFDAApprovedProduct.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's number of fda approved product.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's number of FDA approved product?: ADMA Biologics (ADMA) reported number of FDA approved product of 3 in Q1 2026.
What does number of FDA approved product mean?: The total count of proprietary products that have received formal regulatory authorization for commercial sale. This metric measures the maturity of the product pipeline and the company's ability to successfully navigate the clinical and regulatory approval process.